TickerFactsScreenerDevelopers

Tempest Therapeutics, Inc. (TPST) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2013: -$18.09M2014: -$30.59M2015: -$50.29M2016: -$61.73M2017: -$20.34M2018: -$23.65M2019: -$41.22M2020: -$19.02M2021: -$25.96M2022: -$31.07M2023: -$27.36M2024: -$33.03M2025: -$26.82M-$26.82M
2013Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$26.82M+18.8%
2024-$33.03M-20.7%
2023-$27.36M+12.0%
2022-$31.07M-19.7%
2021-$25.96M-36.5%
2020-$19.02M+53.9%
2019-$41.22M-74.3%
2018-$23.65M-16.3%
2017-$20.34M+67.1%
2016-$61.73M-22.8%
2015-$50.29M-64.4%
2014-$30.59M-69.1%
2013-$18.09M—